Parsaclisib (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Parsaclisib" in English language version.

refsWebsite

Global rank English rank

2^nd place

2^nd place

102^nd place

76^th place

4^th place

4^th place

274^th place

309^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Gerds AT, Bartalucci N, Assad A, Yacoub A (August 2022). "Targeting the PI3K pathway in myeloproliferative neoplasms". Expert Review of Anticancer Therapy. 22 (8): 835–843. doi:10.1080/14737140.2022.2093192. hdl:2158/1351132. PMID 35763287.

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Gerds AT, Bartalucci N, Assad A, Yacoub A (August 2022). "Targeting the PI3K pathway in myeloproliferative neoplasms". Expert Review of Anticancer Therapy. 22 (8): 835–843. doi:10.1080/14737140.2022.2093192. hdl:2158/1351132. PMID 35763287.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Gerds AT, Bartalucci N, Assad A, Yacoub A (August 2022). "Targeting the PI3K pathway in myeloproliferative neoplasms". Expert Review of Anticancer Therapy. 22 (8): 835–843. doi:10.1080/14737140.2022.2093192. hdl:2158/1351132. PMID 35763287.

springer.com (Global: 274^th place; English: 309^th place)

adisinsight.springer.com

"Parsaclisib - Incyte Corporation". AdisInsight. Springer Nature Switzerland AG.